Manchester Professor of Gynaecological Oncology Emma Crosbie, has been awarded major funding by the NIHR, to investigate whether urine testing can be used to screen women for risk of cervical cancer.
Read more
Early results for a potentially revolutionary brain disease therapy given under compassionate use to a two-year-old has shown promise
Read more
MFT has continued its contribution to the global fight against Coronavirus by enrolling patients in a ground-breaking new study of the virus.
Read more
Professor Gareth Evans, a leading breast cancer geneticist and Consultant in MFT's Saint Mary’s Hospital, has been elected as a fellow for the prestigious Learned Society of Wales.
Read more
Our first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).
Read more
Our first patient has taken part in an interventional research trial testing potential treatments for people with severe COVID-19 infection, being cared for in an Intensive Care Unit.
Read more
Our first patient has taken part in the PRIEST study, a research trial aiming to optimise the triage of people using the emergency care system during the COVID-19 (coronavirus) pandemic.
Read more
The Kellgren Centre for Rheumatology at Manchester University NHS Foundation Trust (MFT) has won a national award for its work with patients with rheumatoid arthritis.
Read more
